{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "CitationSubset": ["IM"], "OtherAbstract": [], "KeywordList": [["IL-13", "IL-33", "asthma", "microbiome", "tumor necrosis factor-\u03b1"]], "GeneralNote": [], "OtherID": [], "InvestigatorList": [], "PMID": "29161088", "DateCompleted": {"Year": "2018", "Month": "07", "Day": "24"}, "DateRevised": {"Year": "2019", "Month": "08", "Day": "20"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.1513/AnnalsATS.201702-140AW"], "Journal": {"ISSN": "2325-6621", "JournalIssue": {"Volume": "14", "Issue": "Supplement_5", "PubDate": {"Year": "2017", "Month": "Nov"}}, "Title": "Annals of the American Thoracic Society", "ISOAbbreviation": "Ann Am Thorac Soc"}, "ArticleTitle": "Mechanistic Basis for Obesity-related Increases in Ozone-induced Airway Hyperresponsiveness in Mice.", "Pagination": {"StartPage": "S357", "EndPage": "S362", "MedlinePgn": "S357-S362"}, "Abstract": {"AbstractText": ["Obesity is a risk factor for asthma, especially nonallergic asthma. Ozone, a common air pollutant, is a nonallergic asthma trigger. Importantly, ozone-induced decrements in lung function are greater in obese and overweight human subjects than in lean individuals. Obese mice also exhibit exaggerated pulmonary responses to ozone. Ozone causes greater increases in pulmonary resistance, in bronchoalveolar lavage neutrophils, and in airway hyperresponsiveness in obese than in lean mice. Our data indicate that IL-33 plays a role in mediating these events. Ozone causes greater release of IL-33 into bronchoalveolar lavage fluid in obese than in lean mice. Furthermore, an antibody blocking the IL-33 receptor, ST2, attenuates ozone-induced airway hyperresponsiveness in obese but not in lean mice. Our data also indicate a complex role for tumor necrosis factor (TNF)-\u03b1 in obesity-related effects on the response to ozone. In obese mice, genetic deficiency in either TNF-\u03b1 or TNF-\u03b1 receptor 2 augments ozone-induced airway hyperresponsiveness, whereas TNF-\u03b1 receptor 2 deficiency virtually abolishes ozone-induced airway hyperresponsiveness in lean mice. Finally, obesity is known to alter the gut microbiome. In female mice, antibiotics attenuate obesity-related increases in the effect of ozone on airway hyperresponsiveness, possibly by altering microbial production of short-chain fatty acids. Asthma control is often difficult to achieve in obese patients with asthma. Our data suggest that therapeutics directed against IL-33 may ultimately prove effective in these patients. The data also suggest that dietary manipulations and other strategies (prebiotics, probiotics) that alter the microbiome and/or its metabolic products may represent a new frontier for treating asthma in obese individuals."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Environmental Health, Harvard T. H. Chan School of Public Health, Boston, Massachusetts."}], "Identifier": [], "LastName": "Shore", "ForeName": "Stephanie A", "Initials": "SA"}], "GrantList": [{"GrantID": "P30 ES000002", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}, {"GrantID": "R01 ES013307", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}, {"GrantID": "R21 ES024032", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Ann Am Thorac Soc", "NlmUniqueID": "101600811", "ISSNLinking": "2325-6621"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Bacterial Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Il33 protein, mouse"}, {"RegistryNumber": "0", "NameOfSubstance": "Interleukin-33"}, {"RegistryNumber": "0", "NameOfSubstance": "Tumor Necrosis Factor-alpha"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Anti-Bacterial Agents"}, {"QualifierName": ["cytology"], "DescriptorName": "Bronchoalveolar Lavage Fluid"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["antagonists & inhibitors"], "DescriptorName": "Interleukin-33"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Obese"}, {"QualifierName": [], "DescriptorName": "Microbiota"}, {"QualifierName": ["complications"], "DescriptorName": "Obesity"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Ozone"}, {"QualifierName": ["chemically induced", "drug therapy"], "DescriptorName": "Respiratory Hypersensitivity"}, {"QualifierName": ["antagonists & inhibitors"], "DescriptorName": "Tumor Necrosis Factor-alpha"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Shore SA. Obesity and asthma: possible mechanisms. J Allergy Clin Immunol. 2008;121:1087\u20131095.", "ArticleIdList": ["18405959"]}, {"Citation": "Stream AR, Sutherland ER. Obesity and asthma disease phenotypes. Curr Opin Allergy Clin Immunol. 2012;12:76\u201381.", "ArticleIdList": ["22157152"]}, {"Citation": "Sutherland ER. Linking obesity and asthma. Ann N Y Acad Sci. 2014;1311:31\u201341.", "ArticleIdList": ["24517401"]}, {"Citation": "Boulet LP, Turcotte H, Martin J, Poirier P. Effect of bariatric surgery on airway response and lung function in obese subjects with asthma. Respir Med. 2012;106:651\u2013660.", "ArticleIdList": ["22326605"]}, {"Citation": "Dixon AE, Pratley RE, Forgione PM, Kaminsky DA, Whittaker-Leclair LA, Griffes LA, Garudathri J, Raymond D, Poynter ME, Bunn JY, et al. Effects of obesity and bariatric surgery on airway hyperresponsiveness, asthma control, and inflammation. J Allergy Clin Immunol. 2011;128:508\u2013515.e2.", "ArticleIdList": ["PMC3164923", "21782230"]}, {"Citation": "Wenzel SE. Emergence of biomolecular pathways to define novel asthma phenotypes: type-2 immunity and beyond. Am J Respir Cell Mol Biol. 2016;55:1\u20134.", "ArticleIdList": ["PMC4942211", "27164162"]}, {"Citation": "Dixon AE, Shade DM, Cohen RI, Skloot GS, Holbrook JT, Smith LJ, Lima JJ, Allayee H, Irvin CG, Wise RA American Lung Association-Asthma Clinical Research Centers. Effect of obesity on clinical presentation and response to treatment in asthma. J Asthma. 2006;43:553\u2013558.", "ArticleIdList": ["16939998"]}, {"Citation": "Pradeepan S, Garrison G, Dixon AE. Obesity in asthma: approaches to treatment. Curr Allergy Asthma Rep. 2013;13:434\u2013442.", "ArticleIdList": ["PMC3778029", "23619597"]}, {"Citation": "Sutherland ER, Goleva E, Strand M, Beuther DA, Leung DY. Body mass and glucocorticoid response in asthma. Am J Respir Crit Care Med. 2008;178:682\u2013687.", "ArticleIdList": ["PMC2556450", "18635892"]}, {"Citation": "van Veen IH, Ten Brinke A, Sterk PJ, Rabe KF, Bel EH. Airway inflammation in obese and nonobese patients with difficult-to-treat asthma. Allergy. 2008;63:570\u2013574.", "ArticleIdList": ["18394131"]}, {"Citation": "Wenzel SE. Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med. 2012;18:716\u2013725.", "ArticleIdList": ["22561835"]}, {"Citation": "Visness CM, London SJ, Daniels JL, Kaufman JS, Yeatts KB, Siega-Riz AM, Calatroni A, Zeldin DC. Association of childhood obesity with atopic and nonatopic asthma: results from the National Health and Nutrition Examination Survey 1999\u20132006. J Asthma. 2010;47:822\u2013829.", "ArticleIdList": ["PMC2975947", "20707763"]}, {"Citation": "Baumann S, Lorentz A. Obesity: a promoter of allergy? Int Arch Allergy Immunol. 2013;162:205\u2013213.", "ArticleIdList": ["24021931"]}, {"Citation": "Foster WM, Brown RH, Macri K, Mitchell CS. Bronchial reactivity of healthy subjects: 18\u201320 h postexposure to ozone. J Appl Physiol (1985) 2000;89:1804\u20131810.", "ArticleIdList": ["11053329"]}, {"Citation": "Gent JF, Triche EW, Holford TR, Belanger K, Bracken MB, Beckett WS, Leaderer BP. Association of low-level ozone and fine particles with respiratory symptoms in children with asthma. JAMA. 2003;290:1859\u20131867.", "ArticleIdList": ["14532314"]}, {"Citation": "Ji M, Cohan DS, Bell ML. Meta-analysis of the association between short-term exposure to ambient ozone and respiratory hospital admissions. Environ Res Lett. 2011;6(2):024006.", "ArticleIdList": ["PMC3138529", "21779304"]}, {"Citation": "Dong GH, Qian Z, Liu MM, Wang D, Ren WH, Fu Q, Wang J, Simckes M, Ferguson TF, Trevathan E. Obesity enhanced respiratory health effects of ambient air pollution in Chinese children: the Seven Northeastern Cities study. Int J Obes. 2013;37:94\u2013100.", "ArticleIdList": ["22846775"]}, {"Citation": "Alexeeff SE, Litonjua AA, Suh H, Sparrow D, Vokonas PS, Schwartz J. Ozone exposure and lung function: effect modified by obesity and airways hyperresponsiveness in the VA Normative Aging Study. Chest. 2007;132:1890\u20131897.", "ArticleIdList": ["17925423"]}, {"Citation": "Bennett WD, Hazucha MJ, Folinsbee LJ, Bromberg PA, Kissling GE, London SJ. Acute pulmonary function response to ozone in young adults as a function of body mass index. Inhal Toxicol. 2007;19:1147\u20131154.", "ArticleIdList": ["PMC2253725", "17987466"]}, {"Citation": "Johnston RA, Theman TA, Lu FL, Terry RD, Williams ES, Shore SA. Diet-induced obesity causes innate airway hyperresponsiveness to methacholine and enhances ozone-induced pulmonary inflammation. J Appl Physiol (1985) 2008;104:1727\u20131735.", "ArticleIdList": ["18323466"]}, {"Citation": "Johnston RA, Theman TA, Shore SA. Augmented responses to ozone in obese carboxypeptidase E-deficient mice. Am J Physiol Regul Integr Comp Physiol. 2006;290:R126\u2013R133.", "ArticleIdList": ["16002559"]}, {"Citation": "Johnston RA, Zhu M, Hernandez CB, Williams ES, Shore SA. Onset of obesity in carboxypeptidase E-deficient mice and effect on airway responsiveness and pulmonary responses to ozone. J Appl Physiol (1985) 2010;108:1812\u20131819.", "ArticleIdList": ["PMC2886692", "20299617"]}, {"Citation": "Lu FL, Johnston RA, Flynt L, Theman TA, Terry RD, Schwartzman IN, Lee A, Shore SA. Increased pulmonary responses to acute ozone exposure in obese db/db mice. Am J Physiol Lung Cell Mol Physiol. 2006;290:L856\u2013L865.", "ArticleIdList": ["16373670"]}, {"Citation": "Mathews JA, Krishnamoorthy N, Kasahara DI, Cho Y, Wurmbrand AP, Ribeiro L, Smith D, Umetsu D, Levy BD, Shore SA. IL-33 drives augmented responses to ozone in obese mice. Environ Health Perspect. 2017;125:246\u2013253.", "ArticleIdList": ["PMC5289908", "27472835"]}, {"Citation": "Shore SA, Rivera-Sanchez YM, Schwartzman IN, Johnston RA. Responses to ozone are increased in obese mice. J Appl Physiol (1985) 2003;95:938\u2013945.", "ArticleIdList": ["12794034"]}, {"Citation": "Williams AS, Mathews JA, Kasahara DI, Chen L, Wurmbrand AP, Si H, Shore SA. Augmented pulmonary responses to acute ozone exposure in obese mice: roles of TNFR2 and IL-13. Environ Health Perspect. 2013;121:551\u2013557.", "ArticleIdList": ["PMC3673194", "23434795"]}, {"Citation": "Williams AS, Mathews JA, Kasahara DI, Wurmbrand AP, Chen L, Shore SA. Innate and ozone-induced airway hyperresponsiveness in obese mice: role of TNF-\u03b1. Am J Physiol Lung Cell Mol Physiol. 2015;308:L1168\u2013L1177.", "ArticleIdList": ["PMC4451401", "25840999"]}, {"Citation": "Shore SA. Obesity, airway hyperresponsiveness, and inflammation. J Appl Physiol (1985) 2010;108:735\u2013743.", "ArticleIdList": ["PMC2838631", "19875711"]}, {"Citation": "Bromberg PA. Mechanisms of the acute effects of inhaled ozone in humans. Biochim Biophys Acta. 2016;1860:2771\u20132781.", "ArticleIdList": ["27451958"]}, {"Citation": "Pino MV, Levin JR, Stovall MY, Hyde DM. Pulmonary inflammation and epithelial injury in response to acute ozone exposure in the rat. Toxicol Appl Pharmacol. 1992;112:64\u201372.", "ArticleIdList": ["1733049"]}, {"Citation": "Pichavant M, Goya S, Meyer EH, Johnston RA, Kim HY, Matangkasombut P, Zhu M, Iwakura Y, Savage PB, DeKruyff RH, et al. Ozone exposure in a mouse model induces airway hyperreactivity that requires the presence of natural killer T cells and IL-17. J Exp Med. 2008;205:385\u2013393.", "ArticleIdList": ["PMC2271004", "18250191"]}, {"Citation": "Lang JE, Williams ES, Mizgerd JP, Shore SA. Effect of obesity on pulmonary inflammation induced by acute ozone exposure: role of interleukin-6. Am J Physiol Lung Cell Mol Physiol. 2008;294:L1013\u2013L1020.", "ArticleIdList": ["18359888"]}, {"Citation": "Ley RE. Obesity and the human microbiome. Curr Opin Gastroenterol. 2010;26:5\u201311.", "ArticleIdList": ["19901833"]}, {"Citation": "Ley RE, B\u00e4ckhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. Obesity alters gut microbial ecology. Proc Natl Acad Sci USA. 2005;102:11070\u201311075.", "ArticleIdList": ["PMC1176910", "16033867"]}, {"Citation": "Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, Sogin ML, Jones WJ, Roe BA, Affourtit JP, et al. A core gut microbiome in obese and lean twins. Nature. 2009;457:480\u2013484.", "ArticleIdList": ["PMC2677729", "19043404"]}, {"Citation": "Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444:1027\u20131031.", "ArticleIdList": ["17183312"]}, {"Citation": "Rosenbaum M, Knight R, Leibel RL. The gut microbiota in human energy homeostasis and obesity. Trends Endocrinol Metab. 2015;26:493\u2013501.", "ArticleIdList": ["PMC4862197", "26257300"]}, {"Citation": "Schroeder BO, B\u00e4ckhed F. Signals from the gut microbiota to distant organs in physiology and disease. Nat Med. 2016;22:1079\u20131089.", "ArticleIdList": ["27711063"]}, {"Citation": "Vijay-Kumar M, Aitken JD, Carvalho FA, Cullender TC, Mwangi S, Srinivasan S, Sitaraman SV, Knight R, Ley RE, Gewirtz AT. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science. 2010;328:228\u2013231.", "ArticleIdList": ["PMC4714868", "20203013"]}, {"Citation": "Cho Y, Shore SA. Obesity, asthma, and the microbiome. Physiology (Bethesda) 2016;31:108\u2013116.", "ArticleIdList": ["PMC4888975", "26889016"]}, {"Citation": "Moffatt MF, Gut IG, Demenais F, Strachan DP, Bouzigon E, Heath S, von Mutius E, Farrall M, Lathrop M, Cookson WO GABRIEL Consortium. A large-scale, consortium-based genomewide association study of asthma. N Engl J Med. 2010;363:1211\u20131221.", "ArticleIdList": ["PMC4260321", "20860503"]}, {"Citation": "Kumagai K, Lewandowski R, Jackson-Humbles DN, Li N, Van Dyken SJ, Wagner JG, Harkema JR. Ozone-induced nasal type 2 immunity in mice is dependent on innate lymphoid cells. Am J Respir Cell Mol Biol. 2016;54:782\u2013791.", "ArticleIdList": ["26559808"]}, {"Citation": "Yang Q, Ge MQ, Kokalari B, Redai IG, Wang X, Kemeny DM, Bhandoola A, Haczku A. Group 2 innate lymphoid cells mediate ozone-induced airway inflammation and hyperresponsiveness in mice. J Allergy Clin Immunol. 2016;137:571\u2013578.", "ArticleIdList": ["PMC4747855", "26282284"]}, {"Citation": "Cayrol C, Girard JP. IL-33: an alarmin cytokine with crucial roles in innate immunity, inflammation and allergy. Curr Opin Immunol. 2014;31:31\u201337.", "ArticleIdList": ["25278425"]}, {"Citation": "Barlow JL, Peel S, Fox J, Panova V, Hardman CS, Camelo A, Bucks C, Wu X, Kane CM, Neill DR, et al. IL-33 is more potent than IL-25 in provoking IL-13-producing nuocytes (type 2 innate lymphoid cells) and airway contraction. J Allergy Clin Immunol. 2013;132:933\u2013941.", "ArticleIdList": ["23810766"]}, {"Citation": "Mizutani N, Nabe T, Yoshino S. IL-17a promotes the exacerbation of IL-33-induced airway hyperresponsiveness by enhancing neutrophilic inflammation via CXCR2 signaling in mice. J Immunol. 2014;192:1372\u20131384.", "ArticleIdList": ["24446518"]}, {"Citation": "Chang YJ, DeKruyff RH, Umetsu DT. The role of type 2 innate lymphoid cells in asthma. J Leukoc Biol. 2013;94:933\u2013940.", "ArticleIdList": ["23801654"]}, {"Citation": "Shore SA, Williams ES, Zhu M. No effect of metformin on the innate airway hyperresponsiveness and increased responses to ozone observed in obese mice. J Appl Physiol (1985) 2008;105:1127\u20131133.", "ArticleIdList": ["PMC2576029", "18703763"]}, {"Citation": "Lin YL, Chen SH, Wang JY. Critical role of IL-6 in dendritic cell-induced allergic inflammation of asthma. J Mol Med (Berl) 2016;94:51\u201359.", "ArticleIdList": ["26232935"]}, {"Citation": "Peters MC, McGrath KW, Hawkins GA, Hastie AT, Levy BD, Israel E, Phillips BR, Mauger DT, Comhair SA, Erzurum SC, et al. National Heart, Lung, and Blood Institute Severe Asthma Research Program. Plasma interleukin-6 concentrations, metabolic dysfunction, and asthma severity: a cross-sectional analysis of two cohorts. Lancet Respir Med. 2016;4:574\u2013584.", "ArticleIdList": ["PMC5007068", "27283230"]}, {"Citation": "Johnston RA, Mizgerd JP, Shore SA. CXCR2 is essential for maximal neutrophil recruitment and methacholine responsiveness after ozone exposure. Am J Physiol Lung Cell Mol Physiol. 2005;288:L61\u2013L67.", "ArticleIdList": ["15361358"]}, {"Citation": "Johnston RA, Schwartzman IN, Flynt L, Shore SA. Role of interleukin-6 in murine airway responses to ozone. Am J Physiol Lung Cell Mol Physiol. 2005;288:L390\u2013L397.", "ArticleIdList": ["15516495"]}, {"Citation": "Kasahara DI, Kim HY, Mathews JA, Verbout NG, Williams AS, Wurmbrand AP, Ninin FM, Neto FL, Benedito LA, Hug C, et al. Pivotal role of IL-6 in the hyperinflammatory responses to subacute ozone in adiponectin-deficient mice. Am J Physiol Lung Cell Mol Physiol. 2014;306:L508\u2013L520.", "ArticleIdList": ["PMC3949085", "24381131"]}, {"Citation": "McCullough SD, Duncan KE, Swanton SM, Dailey LA, Diaz-Sanchez D, Devlin RB. Ozone induces a proinflammatory response in primary human bronchial epithelial cells through mitogen-activated protein kinase activation without nuclear factor-\u03baB activation. Am J Respir Cell Mol Biol. 2014;51:426\u2013435.", "ArticleIdList": ["24693990"]}, {"Citation": "Yagami A, Orihara K, Morita H, Futamura K, Hashimoto N, Matsumoto K, Saito H, Matsuda A. IL-33 mediates inflammatory responses in human lung tissue cells. J Immunol. 2010;185:5743\u20135750.", "ArticleIdList": ["20926795"]}, {"Citation": "Yang Z, Grinchuk V, Urban JF, Jr, Bohl J, Sun R, Notari L, Yan S, Ramalingam T, Keegan AD, Wynn TA, et al. Macrophages as IL-25/IL-33-responsive cells play an important role in the induction of type 2 immunity. PLoS One. 2013;8:e59441.", "ArticleIdList": ["PMC3607614", "23536877"]}, {"Citation": "Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol. 2006;6:772\u2013783.", "ArticleIdList": ["16998510"]}, {"Citation": "Bouter B, Geary N, Langhans W, Asarian L. Diet-genotype interactions in the early development of obesity and insulin resistance in mice with a genetic deficiency in tumor necrosis factor-\u03b1. Metabolism. 2010;59:1065\u20131073.", "ArticleIdList": ["20045154"]}, {"Citation": "Liang H, Yin B, Zhang H, Zhang S, Zeng Q, Wang J, Jiang X, Yuan L, Wang CY, Li Z. Blockade of tumor necrosis factor (TNF) receptor type 1-mediated TNF-\u03b1 signaling protected Wistar rats from diet-induced obesity and insulin resistance. Endocrinology. 2008;149:2943\u20132951.", "ArticleIdList": ["18339717"]}, {"Citation": "Park EJ, Lee JH, Yu GY, He G, Ali SR, Holzer RG, Osterreicher CH, Takahashi H, Karin M. Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell. 2010;140:197\u2013208.", "ArticleIdList": ["PMC2836922", "20141834"]}, {"Citation": "Uysal KT, Wiesbrock SM, Hotamisligil GS. Functional analysis of tumor necrosis factor (TNF) receptors in TNF-\u03b1-mediated insulin resistance in genetic obesity. Endocrinology. 1998;139:4832\u20134838.", "ArticleIdList": ["9832419"]}, {"Citation": "Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS. Protection from obesity-induced insulin resistance in mice lacking TNF-\u03b1 function. Nature. 1997;389:610\u2013614.", "ArticleIdList": ["9335502"]}, {"Citation": "Castro-Giner F, Kogevinas M, Imboden M, de Cid R, Jarvis D, M\u00e4chler M, Berger W, Burney P, Franklin KA, Gonzalez JR, et al. Joint effect of obesity and TNFA variability on asthma: two international cohort studies. Eur Respir J. 2009;33:1003\u20131009.", "ArticleIdList": ["19196817"]}, {"Citation": "Thomas PS, Yates DH, Barnes PJ. Tumor necrosis factor-\u03b1 increases airway responsiveness and sputum neutrophilia in normal human subjects. Am J Respir Crit Care Med. 1995;152:76\u201380.", "ArticleIdList": ["7599866"]}, {"Citation": "Cho HY, Zhang LY, Kleeberger SR. Ozone-induced lung inflammation and hyperreactivity are mediated via tumor necrosis factor-\u03b1 receptors. Am J Physiol Lung Cell Mol Physiol. 2001;280:L537\u2013L546.", "ArticleIdList": ["11159038"]}, {"Citation": "Shore SA, Schwartzman IN, Le Blanc B, Murthy GG, Doerschuk CM. Tumor necrosis factor receptor 2 contributes to ozone-induced airway hyperresponsiveness in mice. Am J Respir Crit Care Med. 2001;164:602\u2013607.", "ArticleIdList": ["11520723"]}, {"Citation": "Cani PD, Delzenne NM, Amar J, Burcelin R. Role of gut microflora in the development of obesity and insulin resistance following high-fat diet feeding. Pathol Biol (Paris) 2008;56:305\u2013309.", "ArticleIdList": ["18178333"]}, {"Citation": "Kimura I, Ozawa K, Inoue D, Imamura T, Kimura K, Maeda T, Terasawa K, Kashihara D, Hirano K, Tani T, et al. The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43. Nat Commun. 2013;4:1829.", "ArticleIdList": ["PMC3674247", "23652017"]}, {"Citation": "Karlsson FH, Tremaroli V, Nookaew I, Bergstr\u00f6m G, Behre CJ, Fagerberg B, Nielsen J, B\u00e4ckhed F. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature. 2013;498:99\u2013103.", "ArticleIdList": ["23719380"]}, {"Citation": "Nagpal R, Kumar M, Yadav AK, Hemalatha R, Yadav H, Marotta F, Yamashiro Y. Gut microbiota in health and disease: an overview focused on metabolic inflammation. Benef Microbes. 2016;7:181\u2013194.", "ArticleIdList": ["26645350"]}, {"Citation": "Abu-Shanab A, Quigley EM. The role of the gut microbiota in nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol. 2010;7:691\u2013701.", "ArticleIdList": ["21045794"]}, {"Citation": "Shore SA, Mathews JA, Brand J, Bell N, Gunst PR, Karoly E. Impact of obesity and ozone on the lung metabolome in mice [abstract] Am J Respir Crit Care Med. 2014;189:A5383."}, {"Citation": "Cho Y, Kasahara DI, Mathews JA, Brand JD, Shore SA. The effects of a depleted gut microbiome on ozone induced airway hyperresponsiveness and inflammation in mice [abstract] Am J Respir Crit Care Med. 2014;189:A6390."}, {"Citation": "Cho Y, Kasahara DI, Abu-Ali G, Huttenhower C, Shore SA. Role of the gut microbiome in obesity-related increases in pulmonary responses to ozone: sex differences [abstract] Am J Respir Crit Care Med. 2016;193:A1077."}, {"Citation": "Cho Y, Kasahara D, Brown TA, Abu-Ali G, Huttenhower C, Shore S. The role of microbiota and short chain fatty acids on in pulmonary responses to ozone. Am J Respir Crit Care Med. 2017;195:A2944."}, {"Citation": "Org E, Parks BW, Joo JW, Emert B, Schwartzman W, Kang EY, Mehrabian M, Pan C, Knight R, Gunsalus R, et al. Genetic and environmental control of host-gut microbiota interactions. Genome Res. 2015;25:1558\u20131569.", "ArticleIdList": ["PMC4579341", "26260972"]}, {"Citation": "Miller PG, Bonn MB, Franklin CL, Ericsson AC, McKarns SC. TNFR2 deficiency acts in concert with gut microbiota to precipitate spontaneous sex-biased central nervous system demyelinating autoimmune disease. J Immunol. 2015;195:4668\u20134684.", "ArticleIdList": ["26475926"]}, {"Citation": "Dixon AE. Obesity: changing asthma in the 21st century. Am J Respir Crit Care Med. 2012;186:395\u2013396.", "ArticleIdList": ["PMC3443799", "22942341"]}]}], "History": [{"Year": "2017", "Month": "11", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "11", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "7", "Day": "25", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "11", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["29161088", "PMC5711270", "10.1513/AnnalsATS.201702-140AW"]}}]}